Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04512872
Recruitment Status : Active, not recruiting
First Posted : August 14, 2020
Last Update Posted : January 26, 2021
Sponsor:
Information provided by (Responsible Party):
Celltrion

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : May 2021
Estimated Study Completion Date : May 2021